2010
|
| |
|
|
|
| 17 August 2010 |
BiondVax Announces Receipt of Ethics ('Helsinki') Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine |

|
English |
| |
|
|
|
| 28 July 2010 |
Frost & Sullivan Awards '2010 European Influenza Vaccines Technology Innovation Award' to BiondVax Pharmaceuticals for Universal Influenza Vaccine |

|
English |
| |
|
|
|
| 14 June 2010 |
BiondVax to Present Universal Flu Vaccine Data at Two Upcoming BioPharma Industry Conferences |

|
English |
| |
|
|
|
| 9 June 2010 |
BiondVax Awarded $1 Million Universal Flu Vaccine Grant from Israeli Office of the Chief Scientist |

|
English |
| |
|
|
|
| 28 April 2010 |
Second successful Phase I/II Clinical Trial for BiondVax’s Universal Flu Vaccine
|

|
English |
| |
|
|
|
| 8 March 2010 |
BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial
|

|
English |
| |
|
|
|
| 24 February 2010 |
BiondVax enters into Term Sheet to secure up to $ 7 Million through a 3 year Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors
|

|
English |
| |
|
|
|
| |
|
|
|
2009
|
| |
|
|
|
| 9 December 2009 |
Successful Stock Offering
|

|
English |
| |
|
|
|
| 7 December 2009 |
Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals’ Universal Flu Vaccine |

|
English |
| |
|
|
|
| 4 October 2009 |
Wayne Rudolph Appointed Vice President of Corporate Development at BiondVax |

|
English |
| |
|
|
|
| 7 September 2009 |
BiondVax will Begin an Additional Clinical Trial: will Examine the Safety of the Universal Flu Vaccine for the Elderly Population |
 |
English |
| |
|
|
|
| 25 August 2009 |
Antibodies for the Swine Flu Virus were Found in the Blood of Mice Injected with BiondVax's Universal Vaccine |
 |
English |
| |
|
|
|
| 3 August 2009 |
Successful Safety Data for BiondVax Even at the Highest Dose of the Universal Flu Vaccine |
 |
English |
| |
|
|
|
| 19 July 2009 |
Success in the Safety Data of 24 Participants in BiondVax's Clinical Trial for a Universal Flu Vaccine; Proceeds to Injection at the Highest Dose |
 |
English |
| |
|
|
|
| 5 July 2009 |
Successful Safety Results in the First Participant Group in BiondVax's Clinical Trial for a Universal Flu Vaccine; the Clinical Trial will be Expanded |
 |
English |
| |
|
|
|